The role of PKCzeta in amikacin-induced apoptosis in the cochlea: prevention by aspirin. - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Apoptosis Année : 2007

The role of PKCzeta in amikacin-induced apoptosis in the cochlea: prevention by aspirin.

Résumé

Aminoglycoside antibiotics are ototoxic, inducing irreversible sensorineural hearing loss mediated by oxidative and excitotoxic stresses. The NF-kappaB pathway is involved in the response to aminoglycoside damage in the cochlea. However, the molecular mechanisms of this ototoxicity remain unclear. We investigated the expression of PKCzeta, a key regulator of NF-kappaB activation, in response to aminoglycoside treatment. Amikacin induced PKCzeta cleavage and nuclear translocation. These events were concomitant with chromatin condensation and paralleled the decrease in NF-kappaB (p65) levels in the nucleus. Amikacin also induced the nuclear translocation of apoptotic inducing factor (AIF). Prior treatment with aspirin prevented PKCzeta cleavage and nuclear translocation. Thus, aspirin counteracts the early effects of amikacin, thereby protecting hair cells and spiral ganglion neurons. These results demonstrate that PKCzeta acts as sentinel connecting specific survival pathways to mediate cellular responses to amikacin ototoxicity.
Fichier sous embargo
Fichier sous embargo
Date de visibilité indéterminée
Loading...

Dates et versions

inserm-00146708 , version 1 (15-05-2007)

Identifiants

Citer

Eric Lecain, Boubaker Omri, Francine Behar-Cohen, Patrice Tran Ba Huy, Patricia Crisanti. The role of PKCzeta in amikacin-induced apoptosis in the cochlea: prevention by aspirin.. Apoptosis, 2007, 12 (2), pp.333-42. ⟨10.1007/s10495-006-0580-0⟩. ⟨inserm-00146708⟩
173 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More